Cargando…
Bradykinin and Neurotensin Analogues as Potential Compounds in Colon Cancer Therapy
Colorectal cancer (CRC) is one of the most lethal malignancies worldwide, so the attempts to find novel therapeutic approaches are necessary. The aim of our study was to analyze how chemical modifications influence physical, chemical, and biological properties of the two peptides, namely, bradykinin...
Autores principales: | Szaryńska, Magdalena, Olejniczak-Kęder, Agata, Podpłońska, Kamila, Prahl, Adam, Iłowska, Emilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253536/ https://www.ncbi.nlm.nih.gov/pubmed/37298595 http://dx.doi.org/10.3390/ijms24119644 |
Ejemplares similares
-
Spectroscopic characterization and in vitro studies of biological activity of bradykinin derivatives
por: Proniewicz, Edyta, et al.
Publicado: (2022) -
Triiodothyronine lowers the potential of colorectal cancer stem cells in vitro
por: Rostkowska, Olga, et al.
Publicado: (2022) -
Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP(9α)
por: Mueller, Sylvia, et al.
Publicado: (2005) -
Novel Bradykinin Analogues Modified in the N-Terminal Part of the Molecule with a Variety of Acyl Substituents
por: Śleszyńska, Małgorzata, et al.
Publicado: (2012) -
Design, Synthesis,
and Biological Evaluation of the
First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor
2
por: Bodin, Sacha, et al.
Publicado: (2023)